Cryoglobulinaemia

D Roccatello, D Saadoun, M Ramos-Casals… - Nature Reviews …, 2018 - nature.com
Cryoglobulinaemia refers to the serum presence of cryoglobulins, which are defined as
immunoglobulins that precipitate at temperatures< 37° C. Type I cryoglobulinaemia consists …

[HTML][HTML] Hepatitis C virus syndrome: A constellation of organ-and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer

C Ferri, M Sebastiani, D Giuggioli… - World journal of …, 2015 - ncbi.nlm.nih.gov
The clinical course of chronic hepatitis C virus (HCV) infection is characterized by possible
development of both liver and extrahepatic disorders. The tropism of HCV for the lymphoid …

[PDF][PDF] Prospective study of guideline‐tailored therapy with direct‐acting antivirals for hepatitis C virus‐associated mixed cryoglobulinemia

L Gragnani, M Visentini, E Fognani, T Urraro… - …, 2016 - Wiley Online Library
Hepatitis C virus (HCV)‐associated mixed cryoglobulinemia (MC) vasculitis commonly
regresses upon virus eradication, but conventional therapy with pegylated interferon and …

Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study

D Saadoun, V Thibault, SNS Ahmed, L Alric… - Annals of the …, 2016 - ard.bmj.com
Background Hepatitis C virus (HCV) is the aetiological agent for most cases of
cryoglobulinaemia vasculitis. Interferon-containing regimens are associated with important …

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts

C Díaz-Lagares, S Croca, S Sangle, EM Vital… - Autoimmunity …, 2012 - Elsevier
OBJECTIVE: To present a pooled analysis of the efficacy of rituximab from European cohorts
diagnosed with biopsy-proven lupus nephropathy (LN) who were treated with rituximab …

Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature

D Giuggioli, F Lumetti, M Colaci, P Fallahi… - Autoimmunity …, 2015 - Elsevier
Background The treatment of systemic sclerosis (SSc) represents a great clinical challenge
because of the complex disease pathogenesis including vascular, fibrotic, and immune T …

Vasculitic neuropathies

KG Gwathmey, TM Burns, MP Collins… - The Lancet …, 2014 - thelancet.com
The vasculitic neuropathies are a diverse group of disorders characterised by the acute-to-
subacute onset of painful sensory and motor deficits that result from inflammatory destruction …

JCS 2017 guideline on management of vasculitis syndrome―digest version―

M Isobe, K Amano, Y Arimura, A Ishizu, S Ito… - Circulation …, 2020 - jstage.jst.go.jp
Vasculitis is a general term for diseases that cause inflammation in the blood vessels
themselves. Table 1 shows the 2012 revised version of Chapel Hill Consensus Conference …

[PDF][PDF] Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry

L Iaccarino, E Bartoloni, L Carli… - Clinical and …, 2015 - research.unipd.it
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre
Registry Page 1 Clinical and Experimental Rheumatology 2015; 33: 449-456. Efficacy and …

[HTML][HTML] International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement

AL Zignego, M Ramos-Casals, C Ferri, D Saadoun… - Autoimmunity …, 2017 - Elsevier
Hepatitis C virus (HCV) is both hepatotrophic and lymphotropic virus that causes liver as
well extrahepatic manifestations including cryoglobulinemic vasculitis, the most frequent and …